Re-Classification with Outcome Correlation of Previously Diagnosed Malignant Phyllodes Tumors Applying the 2016 Consensus Guidelines

Abstract

Background. Classification of phyllodes tumors is challenging due unclear diagnostic criteria, recently addressed by consensus review criteria. Herein, we reviewed all malignant phyllodes tumor resections and reclassified them based on the consensus guidelines, correlating with outcome. We hypothesize that application of criteria would result in a significant proportion being “down-graded” to either borderline or benign phyllodes tumor. Methods. Primary resections of malignant phyllodes tumor were reviewed by four AP board-certified, breast fellowship-trained pathologists. Morphologic variables delineated in consensus guidelines (ie stromal cellularity, cellular atypia, tumor border, presence of heterologous elements, presence of stromal overgrowth) were evaluated. Following review, cases were reclassified as benign, borderline, or malignant. Results. Upon reclassification, 20% (5/20) cases were “down-graded” to borderline phyllodes tumor while 80% (15/20) remained malignant phyllodes tumor. Two morphologic features were statistically significant including broadly infiltrating tumor border in 80% (12/15) of malignant phyllodes tumors compared to none in borderline phyllodes tumor (0/5) (p = 0.004) and stromal overgrowth in 67% (10/15) of malignant phyllodes tumor compared to none in borderline phyllodes tumors (0/5) (p = 0.03). Upon review of the pathology reports, 30% (6/20) contained all 5 histomorphologic variables delineated in the consensus review criteria. Malignant phyllodes tumor resulted in five cases with recurrence (33.3%, 5/15) and three cases with metastases (20.0%, 3/15) and borderline phyllodes tumor resulted in one case with recurrence (20.0%, 1/5) and no metastases (0/5). Conclusion. The consensus guidelines for phyllodes tumor are useful for subclassification. We hypothesize that standardize reporting of the histomorphologic variables may lead to better consensus.

Keywords

malignant borderline phyllodes tumors

Get full access to this article

View all access options for this article.

References

Hawkins

, et al. The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes. Cancer. 1992;69(1):141-147.

Loh

Agarwal

. Contact lens related corneal ulcer. Malays Fam Physician. 2010;5(1):6-8.

Bernstein

Deapen

Ross

. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer. 1993;71(10):3020-3024.

Singer

, et al. Unusual aggressive breast cancer: metastatic malignant phyllodes tumor. J Radiol Case Rep. 2013;7(2):24-37.

Testori

, et al. Huge malignant phyllodes breast tumor: a real entity in a new era of early breast cancer. World J Surg Oncol. 2015;13:81.

Tan

, et al. The 2019 world health organization classification of tumours of the breast. Histopathology. 2020;77(2):181-185.

Tan

, et al. Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol. 2005;123(4):529-540.

Barnes

Pietruszka

. Rhabdomyosarcoma arising within a cystosarcoma phyllodes. Case report and review of the literature. Am J Surg Pathol. 1978;2(4):423-429.

Iihara

, et al. Malignant cystosarcoma phyllodes tumor of the breast mainly composed of chondrosarcoma: a case report. Gen Diagn Pathol. 1997;142(3–4):241-245.

10.

Silver

Tavassoli

. Osteosarcomatous differentiation in phyllodes tumors. Am J Surg Pathol. 1999;23(7):815-821.

11.

Kim

, et al. A rare case of mixed type liposarcoma of breast arising in malignant phyllodes tumor. Breast J. 2020;26(2):271-273.

12.

Azzopardi

Ahmed

Millis

. Problems in breast pathology. Major Probl Pathol. 1979;11:i–xvi. 1–466.

13.

Tan

, et al. Phyllodes tumours of the breast: a consensus review. Histopathology. 2016;68(1):5-21.

14.

Chaney

, et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer. 2000;89(7):1502-1511.

15.

Chen

, et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol. 2005;91(3):185-194.

16.

Sotheran

, et al. Phyllodes tumours of the breast--a retrospective study from 1982–2000 of 50 cases in portsmouth. Ann R Coll Surg Engl. 2005;87(5):339-344.

17.

Cheng

, et al. Phyllodes tumor of the breast: the challenge persists. World J Surg. 2006;30(8):1414-1421.

18.

Reinfuss

, et al. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer. 1996;77(5):910-916.

19.

Barth

Jr . Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat. 1999;57(3):291-295.

20.

Mangi

, et al. Surgical management of phyllodes tumors. Arch Surg. 1999;134(5):487-492. ; discussion 492–3.

21.

Mitus

, et al. Malignant phyllodes tumor of the breast: treatment and prognosis. Breast J. 2014;20(6):639-644.

22.

Tan

, et al. Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol. 2012;65(1):69-76.

23.

Goh

, et al. Cardiopulmonary thromboembolism of epithelioid angiosarcoma arising from malignant phyllodes tumour of the breast. J Clin Pathol. 2014;67(5):450-454.

24.

Abdalla

Sakr

. Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast. J Egypt Natl Canc Inst. 2006;18(2):125-133.

25.

Tan

, et al. Recurrent phyllodes tumours of the breast: pathological features and clinical implications. ANZ J Surg. 2006;76(6):476-480.

26.

Belkacemi

, et al. Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys. 2008;70(2):492-500.

27.

Lenhard

, et al. Phyllodes tumour of the breast: clinical follow-up of 33 cases of this rare disease. Eur J Obstet Gynecol Reprod Biol. 2008;138(2):217-221.

28.

Guillot

, et al. Management of phyllodes breast tumors. Breast J. 2011;17(2):129-137.

29.

Jang

, et al. Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast. Ann Surg Oncol. 2012;19(8):2612-2617.

30.

Sawalhi

Al-Shatti

. Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis. Ann Saudi Med. 2013;33(2):162-168.

31.

Wang

. Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast. Asian Pac J Cancer Prev. 2014;15(24):10791-5.

32.

Bumpers

, et al. Phyllodes tumors in African American women. Am J Surg. 2015;210(1):74-79.

33.

Lyle

, et al. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification. Histopathology. 2016;68(7):1040-1045.

34.

Bacchi

, et al. Lipophyllodes of the breast. A reappraisal of fat-rich tumors of the breast based on 22 cases integrated by immunohistochemical study, molecular pathology insights, and clinical follow-up. Ann Diagn Pathol. 2016;21:1-6.

35.

Inyang

Thomas

Jorns

. Heterologous liposarcomatous differentiation in malignant Phyllodes tumor is histologically similar but immunohistochemically and molecularly distinct from well-differentiated liposarcoma of soft tissue. Breast J. 2016;22(3):282-286.

36.

Rosenberger

, et al. Limited reporting of histopathologic details in a multi-institutional academic cohort of Phyllodes tumors: time for standardization. Ann Surg Oncol. 2021;28(12):7404-7409.